"Farmasintez" realizes the Skolkovo project

@Regiony Rossii
Show original
"Farmasintez" and the resident of a cluster of biomedical technologies Fund "Skolkovo" "the Farm Fusion" signed the license agreement on commercialization of an innovative preparation from PF-114 leukosis. The medicinal candidate of PF-114 – the targetny preparation of the 3rd generation developed by the Russian company "Farm Fusion", is intended for treatment chronic miyeloleykoza (HML) which is not giving in to therapy by preparations of the 1st and 2nd generations. By results of multicenter clinical trial of the 1st phase in the target...
Analysis
×
Vikram Puniya Singkh
Last position: President (Garage cooperative "Farmasintez")
Kirill Kaem
Last position: Senior vice-president for innovations (Fund "Skolkovo")
Tyumenev Xenia
Turkina  Anna
Vinogradova Olga
Garage cooperative "Farmasintez"
Main activity:Health care and social services
Fund "Skolkovo"
Companies